[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR20140018589A - Antimicrobial composition comprising natural plant extract - Google Patents

Antimicrobial composition comprising natural plant extract Download PDF

Info

Publication number
KR20140018589A
KR20140018589A KR1020120084890A KR20120084890A KR20140018589A KR 20140018589 A KR20140018589 A KR 20140018589A KR 1020120084890 A KR1020120084890 A KR 1020120084890A KR 20120084890 A KR20120084890 A KR 20120084890A KR 20140018589 A KR20140018589 A KR 20140018589A
Authority
KR
South Korea
Prior art keywords
extract
antimicrobial composition
kccm
activity
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1020120084890A
Other languages
Korean (ko)
Other versions
KR101784020B1 (en
Inventor
송원섭
부희옥
김동훈
Original Assignee
순천대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 순천대학교 산학협력단 filed Critical 순천대학교 산학협력단
Priority to KR1020120084890A priority Critical patent/KR101784020B1/en
Publication of KR20140018589A publication Critical patent/KR20140018589A/en
Application granted granted Critical
Publication of KR101784020B1 publication Critical patent/KR101784020B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/40Liliopsida [monocotyledons]
    • A01N65/42Aloeaceae [Aloe family] or Liliaceae [Lily family], e.g. aloe, veratrum, onion, garlic or chives
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/40Liliopsida [monocotyledons]
    • A01N65/44Poaceae or Gramineae [Grass family], e.g. bamboo, lemon grass or citronella grass
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Plant Pathology (AREA)
  • Organic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

본 발명은 천연 식물유래 추출물을 유효성분으로 포함하는 항균용 조성물에 관한 것으로서, 자세하게는 히어리, 얼레지, 함초 또는 갈대 추출물을 유효성분으로 함유하는 항균용 조성물에 관한 것이다. 본 발명의 상기 추출물은 각종 병원성 미생물에 대한 항균 활성이 우수하고, 독성이 없으며 미량으로도 효과가 우수하여 각종 항박테리아제, 항진균제, 식품 보존 첨가제, 화장품 첨가제 및 항진균용 농약 등에 유용하게 사용할 수 있는 효과가 있다. The present invention relates to an antimicrobial composition comprising a natural plant-derived extract as an active ingredient, and more particularly, to an antimicrobial composition containing a hyacinth, algae, seaweed or reed extract as an active ingredient. The extract of the present invention is excellent in antimicrobial activity against various pathogenic microorganisms, non-toxic and excellent effect even in a small amount can be usefully used in various antibacterial agents, antifungal agents, food preservative additives, cosmetic additives and antifungal pesticides It works.

Description

천연 식물 추출물을 유효성분으로 포함하는 항균용 조성물{Antimicrobial composition comprising natural plant extract}Antimicrobial composition comprising natural plant extract as an active ingredient

본 발명은 천연식물인 함초, 갈대, 히어리 또는 얼레지의 추출물을 유효성분으로 포함하는 항균용 조성물에 관한 것이다. The present invention relates to an antimicrobial composition comprising extracts of natural plants, reeds, reeds, hyacinths or scabies as active ingredients.

일반적으로 병원성 미생물에 의한 직접 혹은 간접적인 피해는 경제, 환경, 의학적으로 많은 문제를 일으키고 있다. 특히, 식품 산업에서의 식품 유통 과정 중의 부패로 인한 손실, 농산업에서의 농작물에 대한 과량의 화학 살충제의 사용으로 인한 인체의 유해성 및 환경오염, 항생제의 오남용으로 인한 항생제 내성 균주의 출연 등은 이미 사회 전반에서 고질적인 문제가 되고 있다. 이런 현실에서 식물 등에서 분리된 천연 생리 활성 물질들은 병원성 세균, 진균 등의 넓은 범위에서 항생 활성을 나타내지만, 환경 친화적으로 사용할 수 있다는 점에서 새로운 대체 물질로서의 개발이 시급한 실정이다. In general, the direct or indirect damage caused by pathogenic microorganisms causes many economic, environmental and medical problems. In particular, losses due to corruption in the food distribution process in the food industry, the harmful effects of humans and environmental pollution from the use of excessive chemical pesticides on crops in the agricultural industry, and the appearance of antibiotic-resistant strains due to the misuse of antibiotics It becomes a chronic problem in the first half. In this reality, natural bioactive substances isolated from plants exhibit antibiotic activity in a wide range of pathogenic bacteria, fungi, etc., but development of new alternatives is urgent in that they can be used environmentally.

한편, 항생물질은 미생물은 죽이면서 인체 또는 동물에게는 독성이 낮고 체내의 효소 등에 의해 비활성화되지 않는 선택적 독성작용(selective toxicity)을 갖는 물질로서, 이는 주로 DNA의 복제, 유전정보의 전사 및 해독, 전자 에너지의 수송, 세포벽의 생합성 등을 저해함으로써 미생물의 증식을 억제하는 기전을 통해 효과를 나타낸다.On the other hand, antibiotics have a selective toxicity effect that kills microorganisms and is low in humans or animals and is not inactivated by enzymes in the body, such as DNA replication, transcription and translation of genetic information, and electrons. It inhibits the transport of energy, the biosynthesis of the cell wall, and the like through the mechanism of inhibiting the growth of microorganisms.

항생물질은 플레밍(Sir Alexandor Fleming)이 1929년에 페니실린을 처음 발견하고, 플로리(Flory) 등이 1939년에 페니실리움 크리소제늄(Penicillium chrysogenum)의 배양액에서 페니실린을 최초로 분리 및 정제하여 감염성 질환을 가진 수많은 환자의 생명을 구함으로써 기적의 약으로 알려져 왔다. 이후 1959년까지 본격적으로 연구가 이루어지면서 현재까지 항생 치료제로 유용하게 사용되고 있는 벤질페니실린(benzylpenicillin), 스트렙토마이신(streptomycin), 테트라사이클린(tetracyclin) 및 마크로라이드계의 에리트로마이신(erythromycin)등이 개발되었다. The antibiotic was first discovered by Pen Alexinor Fleming in 1929 and by Flory et al. In 1939 for the first time to isolate and purify penicillin from a culture of penicillium chrysogenum. It has been known as a miracle medicine by saving the lives of numerous patients with it. Since 1959, full-fledged research has developed benzylpenicillin, streptomycin, tetracycline, and macrolide erythromycin, which have been used as antibiotics to date. .

그러나 페니실린이 사용된지 얼마 되지 않아, 이에 대한 내성을 가지는 세균들이 등장하기 시작하였고, 또한, 대부분의 항생제는 여러 개의 키랄 중심을 갖고 있을 뿐만 아니라 마크로라이드 또는 펩타이드와 같이복잡한 구조를 갖고 있으므로, 그 합성이 어려울 뿐 아니라 이러한 합성방법 역시 발효방법과 비교하여 그 경제성이 매우 낮은 문제점이 있다. However, soon after penicillin was used, resistant bacteria began to appear, and most antibiotics not only have multiple chiral centers but also have complex structures such as macrolides or peptides. Not only this difficulty, but also the synthesis method has a problem of very low economical compared to the fermentation method.

따라서, 새로운 천연물로부터 효능이 우수한 새로운 항균용 물질의 발굴이 시급한 실정이다. Therefore, it is urgent to find new antimicrobial substances having excellent efficacy from new natural products.

한국공개특허 제2012-0081365호Korean Laid-Open Patent No. 2012-0081365

따라서 본 발명의 목적은 생체에 부작용이 없으면서 항균 활성이 우수한 천연 식물 추출물을 유효성분으로 포함하는 항균용 조성물을 제공하는 것이다. Therefore, an object of the present invention is to provide an antimicrobial composition comprising a natural plant extract having excellent antibacterial activity as an active ingredient without any side effects on the living body.

상기와 같은 본 발명의 목적을 달성하기 위해서, 본 발명은 히어리, 얼레지, 함초 및 갈대로 이루어진 군 중에서 선택되는 1종 이상의 추출물을 유효성분으로 포함하는 항균용 조성물을 제공한다.In order to achieve the object of the present invention as described above, the present invention provides an antimicrobial composition comprising as an active ingredient at least one extract selected from the group consisting of hyacinth, ulji, hamcho and reeds.

본 발명의 일실시예에 있어서, 상기 추출물은 물, 유기용매 또는 이들의 혼합 용매 추출물일 수 있다. In one embodiment of the present invention, the extract may be water, an organic solvent or a mixed solvent extract thereof.

본 발명의 일실시예에 있어서, 상기 유기 용매는 메탄올(methanol), 에탄올(ethanol), 프로판올(propanol), 이소프로판올(isopropanol) 및 부탄올(butanol)로 이루어진 군으로부터 선택된 것일 수 있다.In one embodiment of the present invention, the organic solvent may be selected from the group consisting of methanol (methanol), ethanol (ethanol), propanol (propanol), isopropanol (isopropanol) and butanol (butanol).

본 발명의 일실시예에 있어서, 상기 추출물은 조성물 총 중량에 대하여 0.1 ~ 95중량%로 포함되는 것일 수 있다. In one embodiment of the present invention, the extract may be included in 0.1 to 95% by weight relative to the total weight of the composition.

본 발명의 일실시예에 있어서, 상기 추출물은 히어리, 얼레지, 함초 또는 갈대의 줄기, 잎, 뿌리, 꽃 및 구근으로 이루어진 군 중에서 선택되는 하나의 유기용매 추출물일 수 있다. In one embodiment of the present invention, the extract may be one organic solvent extract selected from the group consisting of stems, leaves, roots, flowers and bulbs of hyacinth, sage, vinegar or reeds.

본 발명의 일실시예에 있어서, 상기 추출물은 Staphylococcus epidermidis(KCCM 35494 표피 포도구균), Staphylococcus aureus(KCCM 11335 황색 포도구균), Pityrosporum ovale(KCCM 지루성 피부염균), Listeria monocytogenes(KCCM 저온성 식중독균), Bacillus subtilis(KCCM 11316 청국장 발효균), Corynebacterium ammoniagenes(KCCM 1174 암모니아 합성균) 및 Candida albicans(KCCM 구강염, 위장염 발생 진균)으로 이루어진 군 중에서 선택되는 하나 이상의 균주를 억제하는 활성을 갖는 것일 수 있다. In one embodiment of the present invention, the extract is Staphylococcus epidermidis (KCCM 35494 epidermal staphylococci), Staphylococcus aureus (KCCM 11335 Staphylococcus aureus), Pityrosporum ovale (KCCM Seborrheic Dermatitis), Listeria monocytogenes (KCCM low temperature food poisoning bacteria), Bacillus subtilis (KCCM 11316 Cheonggukjang Fermented Bacteria), Corynebacterium ammoniagenes (KCCM 1174 Ammonia Synthesis), and Candida albicans (KCCM oralitis, gastroenteritis-producing fungi) may have activity to inhibit one or more strains selected from the group consisting of.

본 발명의 일실시예에 있어서, 상기 추출물은 돼지 유행성 설사 바이러스(porcime epidemic diarrhea virus ; PEDV)의 증식을 억제하는 활성을 갖는 것일 수 있다. In one embodiment of the present invention, the extract may have an activity of inhibiting the growth of porcine epidemic diarrhea virus (PEDV).

본 발명은 천연 식물유래 추출물을 유효성분으로 포함하는 항균용 조성물에 관한 것으로서, 자세하게는 히어리, 얼레지, 함초 또는 갈대 추출물을 유효성분으로 함유하는 항균용 조성물에 관한 것이다. 본 발명의 상기 추출물은 각종 병원성 미생물에 대한 항균 활성이 우수하고, 독성이 없으며 미량으로도 효과가 우수하여 각종 항박테리아제, 항진균제, 식품 보존 첨가제, 화장품 첨가제 및 항진균용 농약 등에 유용하게 사용할 수 있는 효과가 있다. The present invention relates to an antimicrobial composition comprising a natural plant-derived extract as an active ingredient, and more particularly, to an antimicrobial composition containing a hyacinth, algae, seaweed or reed extract as an active ingredient. The extract of the present invention is excellent in antimicrobial activity against various pathogenic microorganisms, non-toxic and excellent effect even in a small amount can be usefully used in various antibacterial agents, antifungal agents, food preservative additives, cosmetic additives and antifungal pesticides It works.

본 발명은 히어리, 얼레지, 함초 및 갈대로 이루어진 군 중에서 선택되는 1종 이상의 추출물을 유효성분으로 포함하는 항균용 조성물을 제공함을 특징으로 한다.The present invention is characterized in that it provides an antimicrobial composition comprising as an active ingredient at least one extract selected from the group consisting of hyacinth, algae, seaweed and reed.

‘히어리(Corylopsis coreana)’는 조록나무과로 전 세계적으로 27속 140종이 있으며, 주로 동아시아에 분포하고 드물게는 북아메리카, 중앙아메리카에도 분포한다. 조록나무과에서도 히어리속은 29종으로, 일본에 5종, 인도에 5종이 있고, 우리나라에는 1종이 생육하고 있다. 우리나라 히어리는 낙엽활엽관목으로 학명이 Corylopsis coreana Uyeki이며, 영명은 korean winter hazel이다. 우리나라의 히어리는 1910년 전남 순천 송광사에서 발견되었으며, 특산식물로 1924년 학계에 등록된 수종이다. 이러한 히어리는 낙엽활엽의 관목으로 수고는 1 내지 5m 까지 자라며 군집을 형성하고 근맹아가 많이 올라와 커다란 집단을 형성하면서 철쭉, 진다래, 참싸리, 팥배나무, 신갈나무와 함께 혼생하며 양지에서 잘 자라고 내한성이 강하여 영하 30도 이하에서도 동해를 입지 않으며, 내건성도 강하여 건조한 토양에서도 잘 자라는 것으로 알려져 있다.`` Corylopsis coreana ) is an evergreen family of 27 genera and 140 species worldwide, mainly distributed in East Asia, and rarely in North and Central America. There are 29 species of genus locusts in the locust family. There are 5 species in Japan, 5 species in India, and 1 species in Korea. Korean hyacinth is deciduous broad-leaved shrub, scientific name Corylopsis coreana Uyeki and the name is korean winter hazel . Korea's hyacinth was found in Songgwangsa, Suncheon, Jeonnam, in 1910. It is a special plant and registered in 1924 in academia. These hyacinths are deciduous broad-leaved shrubs that grow to 1 to 5m, forming clusters, and many neighboring children rise up to form large groups, which grow together with azaleas, jinrae, sesame seeds, red beans and sage trees, and grow well in sunny places. It is strong and does not suffer from the East Sea even below minus 30 degrees. It is also known to grow well in dry soil due to its strong dry resistance.

‘얼레지(Erythronium japonicum)’는 현화식물문 외떡잎식물강 백합목 백합과 여러해살이풀로서, 차전엽산자고(車前葉山慈姑), 가재무릇, 얼러지, 에레지, 얼레기, 비단나물이라고도 불리며 학명은 Erythronium japonicum ( Balrer ) Decne이다. 고산지대의 볕이 잘 드는 숲속에서 무리지어 자라며, 씨에서 싹이 터 꽃이 피기까지 7년 이상 걸리고 3~5월에 꽃이 피는데, 17~20℃가 되면 꽃잎이 달리고 25℃ 이상이 되면 꽃잎이 완전히 뒤로 젖혀진다. 비늘줄기는 흰색에 다육질로, 여러 개가 이어져서 땅속에서 옆으로 뻗어가며, 꽃줄기는 비늘줄기 끝에서 곧추 일어서고 잎이 1~2장 달린다. 전 세계에 24종 정도가 분포하고 드물게 흰색 꽃을 볼 수 있는데, 이는 열성 유전자 때문인 것으로 보인다. 이러한 얼레지는 봄에 나온 잎을 뜯어서 삶은 후 그늘에 말려 나물로 먹고 비늘줄기는 약용한다. 위장기능을 향상시키는 작용이 있어 구토와 설사를 멎게 하며, 두통이나 현기증에도 효과가 있는 것으로 알려져 있다.' Erythronium japonicum ) is a lily and perennial herb that is a monocotyledonous plant in the flowering plant, also called Chajeon Fosanjago, crayfish, algae, erage, algae and silk herb, and the scientific name is Erythronium japonicum ( Balrer ) Decne . It grows in a group of alpine sunny forests, and it takes more than 7 years to grow from seed to flower and blooms in March-May. This leans back completely. The scaly stem is fleshy on white, and several pieces are extended laterally in the ground, and the flower stem stands straight at the end of the scaly stem and leaves 1 ~ 2 sheets. There are about 24 species around the world, and rarely white flowers, which may be due to recessive genes. These stalks are boiled from spring leaves, dried in shade and eaten as herbs, and medicinal scales are medicinal. Gastrointestinal function to improve the action to stop vomiting and diarrhea, headaches and dizziness is also known to be effective.

‘함초(Salicornia herbacea)’는 쌍떡잎식물로 중심자목 명아주과의 한해살이풀로 바닷가에서 자라며 줄기는 마디가 많고 두드러지며 1-2번 갈라지고 마디위에 움푹 들어간 구멍 속에 2-3 송이의 작은 꽃이 숨어 있다. 화피는 역 원추형 다육질로 퉁퉁하며 꼬치 핀 후 자라서 열매를 둘러싼다. 한국, 일본, 중국, 인도 및 북아메리카에 분포하며, 우리나라의 경우 서해안, 갯벌 해안에서 바닷물을 흡수하고 자라는 1년생 초본으로, 육초이면서도 해수 속의 모든 성분을 가지는 것을 특징으로 한다. 이러한 함초는 당뇨개선, 변비, 아토피, 혈액순화 조절, 숙변제거, 성기능 개선 등의 효능이 있는 것으로 알려져 있다. ' Salicornia herbacea ) 'is a dicotyledonous plant that grows on the beach as a yearly herbaceous plant of the main tree, the stem is many and prominent, split 1-2 times, and 2-3 small flowers are hidden in the hollows of the nodes. The husk is inverted conical fleshy, grows after pinching and surrounds the fruit. It is distributed in Korea, Japan, China, India, and North America. In Korea, it is a year-old herb that absorbs and grows seawater on the west coast and the tidal-flat coast. These herbs are known to have effects such as diabetic improvement, constipation, atopy, blood purifying control, elimination of stool, and improvement of sexual function.

‘갈대(Phragmites communis)’는 벼목 볏과의 외떡잎식물로서, 높이 3m의 여러해살이풀로 뿌리줄기는 거칠고 크며 길게 가로 뻗고 마디에서 많은 수염뿌리가 나고 황백색이다. 줄기는 길고 크며 원기둥형이고 단단하며 모여 나고 곧게 선다. 잎은 2줄로 어긋나며 좁고 길이 50㎝, 나비 4㎝ 내외이며 끝이 점점 뾰족하고 가장자리가 거칠거칠하며 녹색이다. 엽초는 털이 없으며 설편(舌片)은 짧고 가장자리에 털이 난다. 꽃은 원추꽃차례로서 대형이며 길이 15∼50㎝이고 줄기 끝에 나며 많은 가지가 갈라지고, 다수의 작은 이삭이 약간 밀착하며 처음에 자색이고 후에 자갈색이 된다. 작은 이삭은 꽃이 5개이고 가늘고 길며 끝이 날카롭다. 습지나 갯가, 호수 주변의 모래땅에 군락을 이루고 자라며 한국 및 북반구의 온대·난대 및 아한대에 분포한다. Phragmites communis ) 'is a monocotyledonous plant with a rice paddy crest. It is a perennial herbaceous plant with a height of 3m and its roots are coarse, large, long, and have many beard roots in the node and yellowish white. Stems are long, large, cylindrical, hard, gathered, and stand upright. Leaves are alternate in 2 lines, narrow, 50cm long, 4cm wide and wide, with sharp tips, rough edges, and green. The leaf is not hairless, the tongue is short, and the hair is on the edge. Flowers are conical inflorescences, large, 15-50cm long, end of stem, many branches are split, many small spikes are in close contact, first purple, and later purple. The small spikes are 5 flowers, long, thin, and sharp. Marsh grows in swamps, mudflats, and sandy areas around lakes, and is distributed in temperate, temperate, and subtropical regions of Korea and the northern hemisphere.

본 발명자들은 이상 기술한 식물인 히어리, 얼레지, 함초 또는 갈대의 추출물이 우수한 항균활성을 가지고 있음을 규명하였는데, 본 발명에 따른 상기 추출물은 당업계에 공지된 추출 및 분리하는 방법을 사용하여 천연으로부터 추출 및 분리하여 수득한 것을 사용할 수 있으며, 본 발명에서 정의된‘추출물’은 적절한 용매를 이용하여 히어리, 얼레지, 함초 또는 갈대 식물로부터 추출한 것이며, 예를 들어, 상기 식물의 조추출물, 극성용매 가용 추출물 또는 비극성용매 가용 추출물을 모두 포함한다. 또한 상기 식물은 구체적으로 식물 전체일 수 있고, 식물의 줄기, 잎, 꽃, 뿌리,구근에서 추출한 추출물일 수 있다.The inventors have found that the extracts of the plants described above, such as hyacinth, sage, seaweed or reed have excellent antimicrobial activity, the extract according to the present invention from the nature using the extraction and separation methods known in the art Extraction and separation can be used, and the 'extract' as defined in the present invention is extracted from hyacinth, sage, seaweed or reed plants using a suitable solvent, for example, crude extract, polar solvent soluble in the plant It includes both extracts or nonpolar solvent soluble extracts. In addition, the plant may specifically be a whole plant, an extract extracted from the stem, leaves, flowers, roots, bulbs of the plant.

상기 추출물을 위해 사용할 수 있는 용매로는 물, 유기용매 또는 이들의 혼합용매를 사용할 수 있는데, 이에 제한되지는 않으나, 정제수, 메탄올(methanol), 에탄올(ethanol), 프로판올(propanol), 이소프로판올(isopropanol), 부탄올(butanol) 등을 포함하는 탄소수 1 내지 4의 알코올, 아세톤(acetone), 에테르(ether), 벤젠(benzene), 클로로포름(chloroform), 에틸아세테이트(ethyl acetate), 메틸렌클로라이드(methylene chloride), 헥산(hexane) 및 시클로헥산(cyclohexane) 등의 각종 용매를 단독으로 혹은 혼합하여 사용할 수 있다. As a solvent that can be used for the extract, water, an organic solvent or a mixed solvent thereof may be used, but is not limited thereto, but may be purified water, methanol, ethanol, propanol or isopropanol. Alcohol containing 1 to 4 carbon atoms, butanol, etc., acetone, ether, benzene, chloroform, ethyl acetate, methylene chloride , Various solvents such as hexane and cyclohexane can be used alone or in combination.

추출 방법으로는 열수추출법, 냉침추출법, 환류냉각추출법, 용매추출법, 수증기증류법, 초음파추출법, 용출법, 압착법 등의 방법 중 어느 하나를 선택하여 사용할 수 있다. 또한, 목적하는 추출물은 추가로 통상의 분획 공정을 수행할 수도 있으며, 통상의 정제 방법을 이용하여 정제될 수도 있다. As the extraction method, any one of the methods such as hot water extraction method, cold extraction method, reflux cooling extraction method, solvent extraction method, steam distillation method, ultrasonic extraction method, elution method and compression method can be selected and used. In addition, the desired extract may be further subjected to a conventional fractionation process or may be purified using a conventional purification method.

또한 본 발명의 조성물에 포함되는 히어리, 얼레지, 함초 또는 갈대로부터 수득한 추출물은 상기한 열수 추출 또는 용매 추출법으로 추출된 1차 추출물을, 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조할 수 있다. 또한 상기 1차 추출물을 실리카겔 컬럼 크로마토그래피(silica gel column chromatography), 박층 크로마토그래피(thin layer chromatography), 고성능 액체 크로마토그래피(high performance liquid chromatography) 등과 같은 다양한 크로마토그래피를 이용하여 추가로 정제된 분획을 얻을 수도 있다.In addition, the extract obtained from the hyacinth, ulji, seaweed or reeds included in the composition of the present invention is the powder obtained by the additional process such as distillation under reduced pressure and freeze drying or spray drying, extracted by hot water extraction or solvent extraction method described above. It can manufacture in a state. Further, the primary extract can be further purified by using various chromatographies such as silica gel column chromatography, thin layer chromatography, high performance liquid chromatography and the like, You can get it.

따라서 본 발명에 있어서 히어리, 얼레지, 함초 또는 갈대로부터 수득한 추출물은 추출, 분획 또는 정제의 각 단계에서 얻어지는 모든 추출액, 분획 및 정제물, 그들의 희석액, 농축액 또는 건조물을 모두 포함하는 개념이다.Therefore, in the present invention, the extract obtained from hyacinth, sage, seaweed or reed is a concept including all extracts, fractions and purified products obtained at each step of extraction, fractionation or purification, their dilutions, concentrates or dried products.

또한, 본 발명의 추출물은 본 발명의 항균 조성물에 10 내지 100000ppm의 농도로 포함될 수 있으며, 또한 본 발명의 상기 추출물은 조성물 총 중량에 대하여 0.1 ~ 95중량%로 포함될 수 있다.In addition, the extract of the present invention may be included in a concentration of 10 to 100,000 ppm in the antimicrobial composition of the present invention, the extract of the present invention may also be included in 0.1 to 95% by weight relative to the total weight of the composition.

한편, 본 발명에 따른 상기 항균용 조성물은 유해 균주인 Staphylococcus epidermidis(KCCM 35494 표피 포도구균), Staphylococcus aureus(KCCM 11335 황색 포도구균), Pityrosporum ovale(KCCM 지루성 피부염균), Listeria monocytogenes(KCCM 저온성 식중독균), Bacillus subtilis(KCCM 11316 청국장 발효균), Corynebacterium ammoniagenes(KCCM 1174 암모니아 합성균) 및 Candida albicans(KCCM 구강염, 위장염 발생 진균)으로 이루어진 군 중에서 선택되는 하나 이상의 균주를 억제하는 활성을 갖는 특징이 있으며, 또한 돼지 유행성 설사 바이러스(porcime epidemic diarrhea virus ; PEDV)의 증식을 억제하는 활성을 갖는다.On the other hand, the antimicrobial composition according to the present invention is a harmful strain Staphylococcus epidermidis (KCCM 35494 epidermal staphylococci), Staphylococcus aureus (KCCM 11335 Staphylococcus aureus), Pityrosporum ovale (KCCM Seborrheic Dermatitis), Listeria monocytogenes (KCCM low temperature food poisoning bacteria), Bacillus subtilis (KCCM 11316 Cheonggukjang Fermented Bacteria), Corynebacterium ammoniagenes (KCCM 1174 ammonia-synthesizing bacteria) and Candida albicans (KCCM oralitis, gastroenteritis-producing fungi) and have the activity of inhibiting one or more strains selected from the group, and also epidemic diarrhea virus (porcime epidemic diarrhea virus; PEDV). ) Inhibits proliferation.

따라서 본 발명에 따른 히어리, 얼레지, 함초 및 갈대로 이루어진 군 중에서 선택되는 1종 이상의 추출물을 유효성분으로 포함하는 항균용 조성물은 각종 병원성 미생물에 대한 항균 활성이 우수하고, 독성이 없으며 미량으로도 효과가 우수하여 각종 항박테리아제, 항진균제, 식품 보존 첨가제, 화장품 첨가제 및 항진균용 농약 등에 유용하게 사용될 수 있다.
Therefore, the antimicrobial composition comprising one or more extracts selected from the group consisting of hyacinth, algae, seaweed and reeds according to the present invention as an active ingredient has excellent antimicrobial activity against various pathogenic microorganisms, and is non-toxic and effective even in trace amounts. It is excellent in various antibacterial agents, antifungal agents, food preservative additives, cosmetic additives and antifungal pesticides can be usefully used.

이하, 실시예를 통하여 본 발명을 보다 상세히 설명하고자 한다. 이들 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are for further illustrating the present invention, and the scope of the present invention is not limited to these examples.

<< 실시예Example 1> 1>

식물별 메탄올 및 에탄올 추출물의 제조Preparation of Methanol and Ethanol Extracts by Plants

함초의 줄기와 잎, 갈대의 뿌리와 잎, 히어리의 꽃, 줄기, 잎, 얼레지의 꽃, 잎, 구근을 실온에서 음건하여 분쇄기로 분쇄한 후 분쇄물 시료 중량의 100배에 해당하는 메탄올과 에탄올을 각각 첨가하여 4주간 침적한 후 여과시킨 다음 회전식 저온 감압 농축기를 이용하여 각 추출 용매를 제건한 후, 동결 건조시킨 추출물을 하기 실험에 사용하였다.
Stems and leaves of seaweed, roots and leaves of reeds, flowers, stems, leaves, flowers of flowers, leaves, and bulbs of hyacinth are dried at room temperature and crushed with a pulverizer. Each of them was added, and the mixture was immersed for 4 weeks, filtered, and each extractive solvent was dried using a rotary low pressure vacuum concentrator, and then the lyophilized extract was used in the following experiment.

<< 실험예Experimental Example 1> 1>

항균활성 측정Antimicrobial Activity

상기 실시예 1에서 수득한 각 식물의 부위별 메탄올 및 에탄올 추출물을 대상으로 하기 표 1에 기재된 유해성 균주들에 대한 항균활성을 조사하였다. 항균 활성 분석은 disc 한천 배지 확산법으로 측정하였다(Bauer 등, 1996). 즉, 5, 10, 15, 20 ㎎·mL-1 농도의 각 추출물을 0.45㎛ 멤브레인 필터(Millipore Co., USA)로 여과하여 제균한 다음 멸균된 필터 페이퍼 디스크filter paper disc(8mm, Whatman, USA)에 50㎕씩 흡수시킨 후, 추출 용매를 무균적으로 풍건하여 완전히 제거한 다음 각각의 균을 생육 적온에서 24시간 동안 배양하여, paper disc 주변의 투명 저지대의 직경(mm)을 측정하여 항균 활성을 비교하였다.
The antimicrobial activity of the harmful strains described in Table 1 was investigated in the methanol and ethanol extracts of the parts of each plant obtained in Example 1. Antimicrobial activity analysis was determined by disc agar medium diffusion (Bauer et al., 1996). That is, each extract having a concentration of 5, 10, 15, 20 mg · mL −1 was filtered through a 0.45 μm membrane filter (Millipore Co., USA) to sterilize, and then sterilized filter paper disc filter paper disc (8 mm, Whatman, USA). 50μl), and extract solvents are aseptically air-dried to remove them completely, and each bacteria are incubated at growth temperature for 24 hours, and the diameter of the transparent low zone around the paper disc is measured to determine the antimicrobial activity. Compared.

Figure pat00001
Figure pat00001

분석 결과, 함초의 경우 메탄올 추출물은 Staphylococcus epidermidis(표피 포도구균),Staphylococcus aureus(황색 포도구균),Pityrosporum ovale(지루성 피부염균), Listeria monocytogenes(저온성 식중독균), Bacillus subtilis(청국장 발효균), Corynebacterium ammoniagenes(암모니아 합성균), Candida albicans(구강염, 위장염 발생 진균)의 모든 처리구의 15㎕처리 농도에서 항균 활성을 보이기 시작하였으며 20㎕ 처리구에서 가장 양호한 항균 활성을 보였다. 특히 Corynebacterium ammoniagenes , Candida albicans에 대한 항균 활성이 좋았다(하기 표 2 내지 표 5 참조)As a result, methanol extract was found to be Staphylococcus epidermidis (epidermal staphylococci), S taphylococcus aureus (yellow staphylococcus aureus), Pityrosporum ovale (seborrheic dermatitis), Listeria monocytogenes (thermic food poisoning bacterium ), Bacillus subtilis (Cheongkukjang fermented bacteria), Corynebacterium ammoniagenes , Candida All treatments of albicans (oral infection, gastroenteritis-producing fungi) began to exhibit antimicrobial activity at 15 μl concentration and the best antibacterial activity at 20μl treatment. Especially Corynebacterium Antimicrobial activity against ammoniagenes and Candida albicans was good (see Tables 2 to 5 below).

에탄올 추출물은 Staphylococcus epidermidis , Pityrosporum ovale , Candida albicans 처리구에서 10㎕ 처리 농도에서 항균 활성을 보이기 시작하였으며, 20㎕ 처리구에서는 좋은 항균 활성을 보였다. 특히 Pityrosporum ovale , Candida albicans 처리구에서 비교적 항균 활성이 좋았다. 이러한 현상은 줄기 처리구에서도 비슷하게 나타났으며 줄기 처리구가 잎 처리구보다 항균활성이 좋게 나타났다.Ethanol Extract Staphylococcus epidermidis , Pityrosporum The ovale and Candida albicans treatments showed antimicrobial activity at the concentration of 10µl. Especially Pityrosporum The antimicrobial activity of ovale and Candida albicans was relatively good. This phenomenon was similar in the stem treatment group and the stem treatment group showed better antibacterial activity than the leaf treatment group.

결론적으로 메탄올과 에탄올 처리구에서 항균 활성을 좋았지만 추출물의 첨가 농도가 많아 질수록 활성이 높게 나타났으며 메탄올 용매 처리구에서 좀 더 나은 항균 활성을 보였다(하기 표 2 내지 표 5 참조).In conclusion, the antimicrobial activity was good in the methanol and ethanol treatments, but the higher the concentration of the extract, the higher the activity and the better antibacterial activity in the methanol solvent treatment treatment (see Tables 2 to 5 below).

Figure pat00002
Figure pat00002

Figure pat00003
Figure pat00003

Figure pat00004
Figure pat00004

Figure pat00005
Figure pat00005

갈대의 경우, 하기 표 6 내지 표9에 나타낸 바와 같이, 뿌리와 잎의 메탄올 추출물은 대부분 추출물의 첨가 농도가 15㎕ 처리구부터 항균 활성이 나타났으며, Staphylococcus epidermidis , Bacillus subtilis , Candida albicans에 대해 20㎕로 많아질수록 모든 항균 처리구가 좋은 활성 반응을 보였다.In the case of reeds, as shown in Tables 6 to 9 below, most of the methanol extracts of the roots and leaves showed antimicrobial activity from 15 µl of the addition concentration of the extracts, and Staphylococcus epidermidis , Bacillus As antimicrobial activity increased to 20μl against subtilis and Candida albicans , all antibacterial treatments showed good activity.

결론적으로 메탄올과 에탄올 처리구에서 항균 활성이 좋았지만 추출물의 첨가 농도가 많아질수록 활성이 높게 나타났으며 특히 메탄올 용매 20㎕ 처리구에서 높은 항균 활성이 나타났다.In conclusion, the antimicrobial activity was good in the methanol and ethanol treatments, but the higher the concentration of the extract, the higher the activity.

Figure pat00006
Figure pat00006

Figure pat00007

Figure pat00007

Figure pat00008
Figure pat00008

Figure pat00009
Figure pat00009

히어리의 경우에는, 하기 표 10 내지 표 15에 나타낸 바와 같이, 함초, 갈대의 경우와 비슷하게 메탄올 추출물은 대부분 추출물의 첨가 농도가 15㎕ 처리구부터 항균 활성이 나타났으며, Staphylococcus epidermidis 처리구에서 가장 높은 항균 활성을 보였으며 Staphylococcus aureus, Bacillus subtilis, Corynebacterium ammoniagenes , Candida albicans 처리구에서도 대채적으로 좋은 활성을 보였으며, 20㎕ 처리 농도에서 항균 활성이 가장 좋았다. 에탄올 처리의 경우는 메탄올 처리시보다 다소 낮은 활성을 보였지만 모든 처리구에서 항균 활성 반응이 일어났다.In the case of hydroxya, as shown in Tables 10 to 15 below, methanol extracts showed the antimicrobial activity from 15 μl treatment of most extracts, and the highest antibacterial activity of Staphylococcus epidermidis treatment It was active, and was found to be S taphylococcus aureus, Bacillus subtilis, Corynebacterium ammoniagenes , Candida The albicans treatment showed good activity, and the antimicrobial activity was the best at 20µl treatment. Ethanol treatment showed slightly lower activity than methanol treatment, but antibacterial activity occurred in all treatments.

Figure pat00010
Figure pat00010

Figure pat00011
Figure pat00011

Figure pat00012
Figure pat00012

Figure pat00013
Figure pat00013

Figure pat00014
Figure pat00014

Figure pat00015
Figure pat00015

얼레지의 경우에는, 표 16 내지 표 21에 기재된 바와 같이, 메탄올 추출물은 첨가농도가 10㎕ 처리구부터 항균 활성을 보이기 시작하였으며 20㎕ 처리구에서 항균 활성이 대부분 나타났고 Bacillus subtilis , Candida albicans 처리구에서 대체적으로 좋은 활성을 보였으며, 20㎕ 처리 농도에서 항균 활성이 좋은 것으로 나타났다. 에탄올 처리의 경우는 메탄올 처리시보다 다소 낮은 활성을 보였지만 모든 처리구에서 활성 반응이 일어났다. In the case of Algeol, as shown in Table 16 to Table 21, the methanol extract began to show antimicrobial activity at the concentration of 10 μl treatment and showed most antibacterial activity at 20 μl treatment and Bacillus subtilis , Candida Albicans treatment showed good activity, and antimicrobial activity was good at 20µl treatment. In the case of ethanol treatment, the activity was slightly lower than that in methanol treatment, but the reaction occurred in all treatments.

결론적으로 얼레지의 항균 활성은 구근>꽃>잎 순으로 나타났으며 메탄올 추출 처리구에서 더 좋은 항균 반응을 보였다.In conclusion, the antimicrobial activity of the larvae was in the order of bulb> flower> leaf.

Figure pat00016
Figure pat00016

Figure pat00017
Figure pat00017

Figure pat00018
Figure pat00018

Figure pat00019
Figure pat00019

Figure pat00020
Figure pat00020

Figure pat00021

Figure pat00021

<< 실험예Experimental Example 2> 2>

항바이러스 측정Antiviral Measurement

<2-1> 시료 제조<2-1> Sample Preparation

함초의 줄기와 잎, 갈대의 뿌리와 잎, 히어리의 꽃, 줄기, 잎, 얼레지의 꽃, 잎, 구근을 실온에서 음건하여 분쇄기로 분쇄한후 시료중량의 100배의 methanol, ethanol를 첨가하여 4주간 침적한 후 여과시켜 회전식 저온 감압 농축기를 이용하여 추출 용매를 제건한 후 동결 건조시켜 실험에 이용하였다.
Stems and leaves of the grasswort, roots and leaves of reeds, flowers, stems, leaves, and flowers of hyacinths, stems, leaves, and bulbs are dried at room temperature and pulverized with a grinder, followed by adding methanol and ethanol at 100 times the sample weight. After immersion for a day and filtered, the extraction solvent was dried using a rotary low pressure vacuum concentrator and then lyophilized to be used for the experiment.

<2-2> 바이러스 배양<2-2> Virus Culture

PEDV에 대한 각각의 추출물의 항바이러스성을 측정하기 위하여 이용된 Virus는 돼지 유행성 설사바이러스(PEDV)를 대상으로 하였으며 Vero세포에서 배양하였다. 또한 소아태아 혈청이 10% 포함된 minimal essential media 배지를 이용하였다.
The virus used to measure the antivirality of each extract against PEDV was porcine epidemic diarrhea virus (PEDV) and cultured in Vero cells. In addition, a minimal essential media medium containing 10% of pediatric serum was used.

<2-3> 바이러스 억제 분석<2-3> virus inhibition assay

PEDV에 대한 함초, 갈대, 히어리, 얼레지 각 식물들의 바이러스 증식능을 측정하기 위하여 Vero세포를 96 well plates에서 배양하였고, 각 세포들이 90%이사 well의 바닥에 있을 때 기존 배양액을 제거하고, PEDV가 포함된 새로운 배양액을 각 well에 투여하였다. 각각의 식물 추출물의 농도는 200, 400, 800 ㎍/㎖로 하여 well에 투여하였다. 각각 식물들의 virus증식억제능의 측정은 PEDV를 48시간 vero세포에 감염시킨 후 각각의 well에 살아있는 세포를 SRB분석법(Martin & Martin, 1997)으로 측정하였다.
Vero cells were cultured in 96 well plates to measure the virus proliferation of the plants, reeds, hyacinths and larvae against PEDV, and when the cells were at the bottom of 90% of the wells, the existing cultures were removed and PEDV was included. New cultures were administered to each well. The concentration of each plant extract was 200, 400, 800 ㎍ / ㎖ administered to the well. The virus proliferation inhibitory activity of each plant was measured by SRB assay (Martin & Martin, 1997) after infecting PEDV with vero cells for 48 hours.

분석 결과, 하기 표 22 내지 표 25에 기재된 바와 같이, 함초의 경우에는 주기에서 잎 추출물 보다 다소 양호한 반응을 보였으며 농도가 높아질수록 의존적으로 항바이러스 활성이 좋게 나타났다. 또한 에탄올 추출물보다 메탄올 추출물에서 더 좋은 항바이러스 반응을 나타냈으며 이러한 현상은 갈대 처리구에서도 비슷하게 나타났다. 갈대의 경우엔 뿌리에서 항바이러스 효과가 좋게 나타났으며 메탄올 추출의 경우에 더 좋은 반응을 보였다.
As a result of the analysis, as shown in Tables 22 to 25, in the case of seaweed, the response was somewhat better than the leaf extract in the cycle, and the higher the concentration, the better the antiviral activity. In addition, methanol extract showed better antiviral response than ethanol extract, and this phenomenon was similar in reed treatment. In the case of reeds, the antiviral effect was good in the roots, and methanol extraction showed better response.

히어리의 경우에는 꽃 >줄기> 잎의 순으로 항바이러스 현상이 나타났고 메탄올 추출의 경우에 더 양호한 반응을 보였다. 또한 첨가 농도가 높아 질수록 항 바이러스 반응이 좋았다. 이러한 현상은 얼레지의 경우에도 비슷하게 나타났으며, 구조>잎>꽃의 순으로 항바이러스 반응을 보였다.
In the case of hydroxya, antiviral phenomena appeared in the order of flowers>stems> leaves, and methanol extracts showed better response. The higher the concentration, the better the antiviral response. This phenomenon was similar in the case of ulge, and showed the antiviral response in the order of structure>leaf> flower.

Figure pat00022
Figure pat00022

Figure pat00023
Figure pat00023

Figure pat00024
Figure pat00024

Figure pat00025

Figure pat00025

이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특허청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.So far I looked at the center of the preferred embodiment for the present invention. It will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention as defined by the appended claims. Therefore, the disclosed embodiments should be considered in an illustrative rather than a restrictive sense. The scope of the present invention is defined by the appended claims rather than by the foregoing description, and all differences within the scope of equivalents thereof should be construed as being included in the present invention.

Claims (7)

히어리, 얼레지, 함초 및 갈대로 이루어진 군 중에서 선택되는 1종 이상의 추출물을 유효성분으로 포함하는 항균용 조성물.Antimicrobial composition comprising one or more extracts selected from the group consisting of hirley, ulji, seaweed and reed as an active ingredient. 제1항에 있어서,
상기 추출물은 물, 유기용매 또는 이들의 혼합 용매 추출물인 것을 특징으로 하는 항균용 조성물.
The method of claim 1,
The extract is an antimicrobial composition, characterized in that water, an organic solvent or a mixed solvent extract thereof.
제2항에 있어서,
상기 유기 용매는 메탄올(methanol), 에탄올(ethanol), 프로판올(propanol), 이소프로판올(isopropanol) 및 부탄올(butanol)로 이루어진 군으로부터 선택된 것을 특징으로 하는 항균용 조성물.
3. The method of claim 2,
The organic solvent is antimicrobial composition, characterized in that selected from the group consisting of methanol (methanol), ethanol (ethanol), propanol (propanol), isopropanol (isopropanol) and butanol (butanol).
제1항에 있어서,
상기 추출물은 조성물 총 중량에 대하여 0.1 ~ 95중량%로 포함되는 것을 특징으로 하는 항균용 조성물.
The method of claim 1,
The extract is an antimicrobial composition, characterized in that contained in 0.1 to 95% by weight based on the total weight of the composition.
제1항에 있어서,
상기 추출물은 히어리, 얼레지, 함초 또는 갈대의 줄기, 잎, 뿌리, 꽃 및 구근 으로 이루어진 군 중에서 선택되는 하나의 유기용매 추출물인 것을 특징으로 하는 항균용 조성물.
The method of claim 1,
The extract is an antimicrobial composition, characterized in that the extract of one organic solvent selected from the group consisting of stems, leaves, roots, flowers and bulbs of hyacinth, sage, seaweed or reeds.
제1항에 있어서,
상기 추출물은 Staphylococcus epidermidis(KCCM 35494 표피 포도구균), Staphylococcus aureus(KCCM 11335 황색 포도구균), Pityrosporum ovale(KCCM 지루성 피부염균), Listeria monocytogenes(KCCM 저온성 식중독균), Bacillus subtilis(KCCM 11316 청국장 발효균), Corynebacterium ammoniagenes(KCCM 1174 암모니아 합성균) 및 Candida albicans(KCCM 구강염, 위장염 발생 진균)으로 이루어진 군 중에서 선택되는 하나 이상의 균주를 억제하는 활성을 갖는 것을 특징으로 하는 항균용 조성물.
The method of claim 1,
The extract is Staphylococcus epidermidis (KCCM 35494 epidermal staphylococci), Staphylococcus aureus (KCCM 11335 Staphylococcus aureus ), Pityrosporum ovale (KCCM seborrheic dermatitis), Listeria monocytogenes (KCCM low temperature food poisoning bacteria), Bacillus subtilis (KCCM 11316 Cheonggukjang Fermented Bacteria), Corynebacterium ammoniagenes (KCCM 1174 Ammonia Synthesis), and Candida Albicans (KCCM oralitis, gastroenteritis-producing fungi) Antimicrobial composition characterized in that it has the activity of inhibiting one or more strains selected from the group consisting of.
제1항에 있어서,
상기 추출물은 돼지 유행성 설사 바이러스(porcime epidemic diarrhea virus ; PEDV)의 증식을 억제하는 활성을 갖는 것을 특징으로 하는 항균용 조성물.
The method of claim 1,
The extract is antimicrobial composition characterized in that it has an activity of inhibiting the growth of porcine epidemic diarrhea virus (PEDV).
KR1020120084890A 2012-08-02 2012-08-02 Antimicrobial composition comprising natural plant extract Active KR101784020B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020120084890A KR101784020B1 (en) 2012-08-02 2012-08-02 Antimicrobial composition comprising natural plant extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120084890A KR101784020B1 (en) 2012-08-02 2012-08-02 Antimicrobial composition comprising natural plant extract

Publications (2)

Publication Number Publication Date
KR20140018589A true KR20140018589A (en) 2014-02-13
KR101784020B1 KR101784020B1 (en) 2017-10-10

Family

ID=50266557

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020120084890A Active KR101784020B1 (en) 2012-08-02 2012-08-02 Antimicrobial composition comprising natural plant extract

Country Status (1)

Country Link
KR (1) KR101784020B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160022190A (en) 2014-08-19 2016-02-29 동신대학교산학협력단 A composition for the treatment or prevention of asthma comprising erythronium japonicum
KR20160069919A (en) 2014-12-09 2016-06-17 목포대학교산학협력단 Anti-inflammatory agent containing allilum hookeri extract
KR101853385B1 (en) * 2017-12-18 2018-04-30 한국식품연구원 Antibacterial composition for inhibiting Pectobacterium carotovorum subsp. Carotovorum comprising Salicornia herbacea extracts as an active ingredient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100729437B1 (en) * 2006-02-22 2007-06-27 한국생명공학연구원 Leaf Extracts with High Antifungal Activity and Isolates from Temaligandin I
CN102512572A (en) * 2012-01-01 2012-06-27 山东大学威海分校 Compound traditional Chinese medicinal preparation and bacteriostatic action thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160022190A (en) 2014-08-19 2016-02-29 동신대학교산학협력단 A composition for the treatment or prevention of asthma comprising erythronium japonicum
KR20160069919A (en) 2014-12-09 2016-06-17 목포대학교산학협력단 Anti-inflammatory agent containing allilum hookeri extract
KR101853385B1 (en) * 2017-12-18 2018-04-30 한국식품연구원 Antibacterial composition for inhibiting Pectobacterium carotovorum subsp. Carotovorum comprising Salicornia herbacea extracts as an active ingredient

Also Published As

Publication number Publication date
KR101784020B1 (en) 2017-10-10

Similar Documents

Publication Publication Date Title
Salazar-Aranda et al. Antimicrobial and antioxidant activities of plants from northeast of Mexico
Tulika et al. Pharmaceutical potential of aquatic plant Pistia stratiotes (L.) and Eichhornia crassipes
Turker et al. Sensitivity of bacteria isolated from fish to some medicinal plants
Mitrović et al. Lichens as source of versatile bioactive compounds
KR100841711B1 (en) Manufacturing method of extract containing high antibiotics by supercritical fluid extraction process
Halawani Antimicrobial activity of Rosa damascena petals extracts and chemical composition by gas chromatography-mass spectrometry (GC/MS) analysis
Rizwana et al. Chemical composition, FTIR studies and antibacterial activity of Passiflora edulis f. edulis (Fruit)
Soliman et al. Seasonal variation in the secondary metabolites and antimicrobial activity of Plantago major L. from Egyptian heterogenic habitats
Abdul-Jalil Lactuca serriola: Short review of its phytochemical and pharmacological profiles
KR20140018589A (en) Antimicrobial composition comprising natural plant extract
Manohar A Review of the Botany, Phytochemistry and Pharmacology of Mangrove Lumnitzera racemosa Willd.
Cherfia et al. Phytochemical analysis, antioxidant and antimicrobial activities of leaves and flowers ethyl acetate and n-butanol fractions from an Algerian endemic plant Calycotome spinosa (L.) Link
Mohan et al. Antimicrobial activity of Oxalis corniculata Linn
Zubair Genetic variation, biochemical contents and wound healing activity of plantago major
CN102757903B (en) Endophytic fungi for producing flavones and application thereof
Aref et al. Variability in antimicrobial activity of latex from two varieties of Ficus carica
Jusković et al. Phytochemical and antimicrobial screening of leaves and stems of Balkan endemic species Daphne malyana Blečić
Gnansounou et al. Dialium guineense Willd. Parkia biglobosa (Jacq.) R. Br. Ex Benth. and Tamarindus indica L.: Review of known and synergetic bioactive compounds
CN101575576A (en) Aspergillus fumigatus and application thereof
Prasetyaningsih et al. Antioxidant and Antimicrobial Potential of Sargassum spp. Extract from Gunungkidul Regency, Indonesia Using Triphasic Extraction Method.
CN100535101C (en) Culture method of dunalilla salina
Kala et al. Antimicrobial activity of Acanthephippium bicolor, Lindley
Castillo et al. Plant extracts from Mexican native species: an alternative for control of plant pathogens
Wang et al. Screen of micro‐organisms for inducing the production of dragon’s blood by leaf of Dracaena cochinchinensis
Biswas et al. Antibacterial activity of two varieties of water chestnuts (Trapa sp.)

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20120802

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20151006

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 20120802

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20160608

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20161223

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20160608

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20161223

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20160808

Comment text: Amendment to Specification, etc.

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170324

Patent event code: PE09021S01D

AMND Amendment
PX0701 Decision of registration after re-examination

Patent event date: 20170921

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20170516

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20170224

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20161223

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20160808

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20170926

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20170926

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20200916

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20210928

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20220919

Start annual number: 6

End annual number: 6